Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent
| Autors principals: | , , , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
BMC
2023-05-01
|
| Col·lecció: | Journal of Translational Medicine |
| Accés en línia: | https://doi.org/10.1186/s12967-023-04186-4 |